Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry
NCT ID: NCT04254237
Last Updated: 2023-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
130 participants
INTERVENTIONAL
2020-02-06
2023-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study we want to compare the supraumbilical versus the infraumbilical location of the laparoscopy entry trocar, in terms of incisional hernia incidence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Using a 5 mm Telescope in Laparoscopic Cholecystectomy Reduce the Incidence of Trocar Site Hernia?
NCT04279223
Umbilical vs Paraumbilical Trocar Placement in Patients Undergoing Elective Laparoscopic Cholecystectomy
NCT04347642
Risk of Umbilical Trocar-site Hernia After SILC Cholecystectomy Versus Conventional Cholecystectomy
NCT01740973
TSH Risk by Extraction Site in Lap Cholecystectomy
NCT06953713
Laparoscopic Cholecystectomy vs Hybrid Natural Orifice Translumenal Surgery
NCT00835250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are many risk factors that have been related to the trocar site hernia development. On one side, the patient clinical factors as the age, presence of obesity, diabetes mellitus or the smoking habits. On the other side, some risk factors related to the surgical technique have been described, as the entry technique, the size and the locations of the trocars, the fascial closure, the duration of the surgery or the infection of the surgical wound.
Regarding the location of the trocars, it seems that the middle line has more risk of incisional hernia than the lateral areas in the abdomen. However, the trocar locations out of the middle line is not always possible, especially in certain surgeries as the laparoscopic cholecystectomy where it can be necessary an expansion of the incision for removing the specimen. In the concrete case of laparoscopic cholecystectomy, the belly is usually the most popular region for placing the first trocar. However, there is not much evidence about the influence of the most popular locations of the umbilical trocar incision (supra or infraumbilical) in the development of incisional hernias.
In the middle line, the infraumbilical region presents a great ability to adapt to pressure changes, as it physiologically occurs during the pregnancy. On the other side, while the primary hernias in the supraumbilical and umbilical region are common, these are not produced in the infraumbilical region. Besides, in anatomical studies of the linea alba, a higher thickness of the fibres in the infraumbilical region has been observed, along with a different spatial arrangement, predominating the transverse fibres in the infraumbilical region and the oblique ones in the supraumbilical region. Therefore, we hypothesize whether the infraumbilical location of the trocar in the midline, theoretically a more protected region, can reduce the incidence of trocar site hernia in our patients.
The aim of this study is to compare the incidence of the Hasson trocar site hernia between the supra and infraumbilical locations a year after surgery, in high risk patients for trocar site hernia subjected to elective laparoscopic cholecystectomy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Infraumbilical Hasson trocar incision.
Infraumbilical Hasson trocar incision
Infraumbilical Hasson trocar incision
Control group
Supraumbilical Hasson trocar incision.
Supraumbilical Hasson trocar incision
Supraumbilical Hasson trocar incision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infraumbilical Hasson trocar incision
Infraumbilical Hasson trocar incision
Supraumbilical Hasson trocar incision
Supraumbilical Hasson trocar incision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand the trial information.
* Patients with symptomatic gallstones or polyps scheduled for laparoscopic cholecystectomy.
* Elective surgery.
* One year potential follow-up.
* Patients that experience one or more of the following Trocar Site Hernia risk factors:
* Over 60 years old.
* Obesity, defined as Body Mass Index (BMI) \> 30 Kg/m2.
* Diabetes mellitus (DM).
* Bronchopathy: A diagnosed Chronic Obstructive Pulmonary Disease (COPD) or smokers of more than 25 cigarette packages/year.
* Accept to participate in the study and sign the informed consent.
Exclusion Criteria
* Patients with previous open supramesocolic surgery.
* Patients with previous surgery that affects the umbilical region.
* Patients with umbilical hernia or history of umbilical hernia surgical correction.
* A greater than 30 cm xifo-umbilical distance.
* Extreme obesity (Body Mass Index \> 50 kg/m2).
* Cancer patients or in immunosuppressive therapy.
* Connective tissue disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Complejo Hospitalario La Mancha Centro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Morandeira Rivas, MD PhD
General Surgeon and Residency program director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Morandeira-Rivas, MD PhD
Role: PRINCIPAL_INVESTIGATOR
La Mancha Centro General Hospital
Carlos Moreno Sanz, MD PhD FACS
Role: STUDY_CHAIR
La Mancha Centro General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
La Mancha Centro General Hospital
Alcázar de San Juan, Ciudad Real, Spain
Tomelloso General Hospital
Tomelloso, Ciudad Real, Spain
Valdepeñas General Hospital
Valdepeñas, Ciudad Real, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
99-B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.